Acadia Pharmaceuticals
ACAD
ACAD
264 hedge funds and large institutions have $2.62B invested in Acadia Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 109 increasing their positions, 80 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0.49% less ownership
Funds ownership: 98.04% → 97.56% (-0.49%)
1% less funds holding
Funds holding: 266 → 264 (-2)
12% less capital invested
Capital invested by funds: $2.99B → $2.62B (-$367M)
Holders
264
Holding in Top 10
5
Calls
$13.5M
Puts
$6.12M
Top Buyers
| 1 | +$47.7M | |
| 2 | +$36.6M | |
| 3 | +$22M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$15.9M |
| 5 |
Morgan Stanley
New York
|
+$15.1M |
Top Sellers
| 1 | -$75.5M | |
| 2 | -$50M | |
| 3 | -$26.4M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$16.8M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$13.7M |